Evidence map›Paper›PMID 28533425›Full record

SynthesisBioscience reports2017

Li-Zhong Lin, Miao-Guo Cai, Yue-Chu Dai, Zhi-Bao Zheng, Fang-Fang Jiang, Li-Li Shi, Yin Pan, Han-Bing Song

Open access · goldAbstract readMeta-Analysis
PubMed Full text at PMC Publisher
In one paragraph

Synthesis in Bioscience reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Li-Zhong LinDepartment of Oncology, Taizhou Central Hospital, Taizhou 318000, P.R. China.
Miao-Guo CaiDepartment of Oncology, Luqiao Branch of Taizhou Hospital, Taizhou 318000, P.R. China.
Yue-Chu DaiDepartment of Oncology, Taizhou Central Hospital, Taizhou 318000, P.R. China.
Zhi-Bao ZhengDepartment of Oncology, Taizhou Central Hospital, Taizhou 318000, P.R. China.
Fang-Fang JiangDepartment of Oncology, Taizhou Central Hospital, Taizhou 318000, P.R. China.
Li-Li ShiDepartment of Infection, Luqiao Branch of Taizhou Hospital, Taizhou 318000, P.R. China.
Yin PanDepartment of Oncology, Taizhou Central Hospital, Taizhou 318000, P.R. China yinpanypp@163.com.
Han-Bing SongDepartment of Infection, Luqiao Branch of Taizhou Hospital, Taizhou 318000, P.R. China.
Taizhou Central Hospital · CNZhejiang Taizhou Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Our aim is to investigate whether or not the breast cancer metastasis suppressor 1 (

Indexed as

Biomarkers, TumorBreast NeoplasmsCase-Control StudiesConfidence IntervalsFemaleGene Expression Regulation, NeoplasticHumansLymphatic MetastasisLymph NodesNeoplasm StagingOdds RatioPrognosisRepressor ProteinsRNA, MessengerStatistics as TopicBiomarkers, TumorBRMS1 protein, humanRepressor ProteinsRNA, MessengerBreast cancerBRMS1Clinico-pathological featuresMeta-analysisMetastasisPrognosis

Identifiers

PMID28533425
PMCPMC5563535
OpenAlexW2619060034

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.